Related Experiment Video
Updated: Feb 12, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
Infant Pulmonary Function Testing and Phenotypes in Severe Bronchopulmonary Dysplasia.
Edward G Shepherd1,2, Brian J Clouse1,3, Kathryn A Hasenstab3
1Comprehensive Center for Bronchopulmonary Dysplasia and the Neonatal Aerodigestive Program, and.
Infant pulmonary function testing identified distinct obstructive, restrictive, and mixed phenotypes in severe bronchopulmonary dysplasia (sBPD) patients. This suggests sBPD management could be personalized based on these identified pulmonary function phenotypes.
Area of Science:
- Neonatal Medicine
- Pediatric Pulmonology
- Respiratory Physiology
Background:
- Severe bronchopulmonary dysplasia (sBPD) management is empirical and varies widely.
- Current sBPD definition relies on respiratory support needs.
- Distinct patient phenotypes within sBPD are suspected but not well-defined.
Purpose of the Study:
- To test the hypothesis that infant pulmonary function testing (iPFT) reveals distinct phenotypes in infants with sBPD.
- To characterize these phenotypes during the initial NICU stay.
Main Methods:
- Prospective cohort study of infants with sBPD (May 2003-June 2016).
- Infant pulmonary function testing (iPFT) used for classification.
- Patients categorized into obstructive, restrictive, or mixed phenotypes based on iPFT data.
Main Results:
- 51% obstructive, 40% mixed, and 9% restrictive phenotypes identified.
- 86% of obstructive and 78% of mixed groups showed moderate/severe obstruction.
- 70% of restrictive patients had moderate restriction; 74% of obstructive and 63% of mixed groups responded to bronchodilators.
Conclusions:
- Severe BPD encompasses distinct pulmonary function phenotypes.
- Future diagnostic approaches should focus on bedside phenotyping.
- Therapeutic trials should consider pulmonary function phenotyping for patient selection.
Related Concept Videos
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Serum Studies: Renal Function Tests
Drug Dosing: Infants and Children
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

